Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial

Abstract Four hundred myopic children randomly received atropine 0.02% (n = 138) or 0.01% (n = 142) in both eyes once-nightly or only wore single-vision spectacles (control group) (n = 120) for 2 years. Spherical equivalent refractive error (SER), axial length (AL), pupil diameter (PD), and amplitud...

Full description

Bibliographic Details
Main Authors: Can Cui, Xiujuan Li, Yong Lyu, Li Wei, Bingxin Zhao, Shiao Yu, Junbo Rong, Yanhui Bai, Aicun Fu
Format: Article
Language:English
Published: Nature Portfolio 2021-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-01708-2

Internet

https://doi.org/10.1038/s41598-021-01708-2

Similar Items